BHC — Bausch Health Companies Share News
0.000.00%
Last trade - 00:00- $2.37bn
- $22.29bn
- $10.27bn
Brief: Bausch Health Companies Inc- Tom Vadaketh Informed Co Of His Decision To Resign As Executive Vice President, Chief Financial Officer Of Company
Bausch Health Companies Inc reports results for the quarter ended in June - Earnings Summary
Appeals court revives whistleblower case accusing Bausch of patent abuse
Bausch + Lomb's Saunders doesn't expect more big deals in the near term (updated)
Bausch Health Companies Inc expected to post earnings of 73 cents a share - Earnings Preview
Canada Stocks: TSX ends lower as Chinese data weighs on commodity prices
Brief: Bausch Health Enters Into $600 Mln Financing Facility With KKR
Bausch + Lomb gains as BofA hikes PT on Xiidra acquisition
Bausch + Lomb surges to record high on Novartis dry-eye drug deal
Bausch + Lomb rises after Novartis dry-eye drug deal
Canada Stocks: TSX ends slightly higher as debt ceiling hopes boost Wall Street
Canada Stocks: TSX rebounds from five-week low as Wall Street rallies
Canada Stocks: Energy and financials help lift Toronto market
Bausch Health jumps as Delaware court guards diarrhea drug's patent
Brief: Bausch Health Companies Inc Says Bausch Health (Excluding. B+L) Confirms 2023 Guidance
Brief: Bausch Health Companies Says CEO Thomas J. Appio's 2022 Total Compensation Was $13.2 Million Versus $10.2 Million In 2021 - SEC Filing
Factbox: US government to impose inflation penalties on 27 drugs
Brief: Richard De Schutter, Karabelas Notified Bausch Health To Retire From Board
Bausch Health Companies Inc expected to post earnings of 91cents a share - Earnings Preview